The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. This research explores using less extensive surgery for cervical cancer and using targeted therapy to reduce the risk of breast cancer recurrence. Read More >>
targeted therapy
June 2, 2023 · ASCO Staff
April 19, 2023 · Greg Guthrie, ASCO staff
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery. Read More >>
March 21, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer. Read More >>
February 16, 2023 · Greg Guthrie, ASCO staff
Read about two studies presented at the 2023 Genitourinary Cancers Symposium, covering plant-based diets and prostate cancer and a promising combination treatment for metastatic castration-resistant prostate cancer. Read More >>
February 14, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Read More >>